Aug 21 2026 03:45 AM EST

Restructuring Uncertainty and Industry Glut Weigh on Braskem Shares After Temporary Margin Surge

Braskem S.A. (NYSE: BAK) shares have fallen 58% in the past three months, trading near 52-week lows at $1.96, as investors confront persistent uncertainty over debt restructuring, negative equity, and the risk that a fleeting Q2 margin windfall will not offset structural pressures in the global petrochemical sector. Despite a jump in quarterly EBITDA from temporary supply disruptions, the company’s high leverage and unresolved balance sheet challenges have kept market sentiment negative.

The company’s second-quarter results highlighted a surge in recurring EBITDA to $1.043 billion, driven by a temporary widening of petrochemical spreads after supply disruptions in the Middle East boosted resin and chemical prices. However, revenue of $4.31 billion missed analyst expectations, and EPS of $1.08 fell short of the $1.27 consensus forecast. Management emphasized that the margin expansion was tactical, not structural, and cautioned that spread normalization and industry overcapacity would resume pressure on earnings.

Temporary Gains Fail to Offset Structural Headwinds

While Braskem’s Q2 profitability benefited from higher spreads, the company’s core challenges remain unresolved. Global overcapacity in polyethylene and polypropylene, especially from China and the US, continues to compress margins. Management and external consultants expect spreads to normalize in the second half of 2026, with Brazil’s PE-naphtha spread projected to fall from $773/ton in Q2 to $316/ton in Q3. The company’s cost disadvantage—relying on naphtha feedstock versus cheaper ethane in the US and Middle East—adds to competitive pressure.

Utilization rates remain weak: Mexico’s polyethylene plant ran at 43% in Q2, down from 55% the prior quarter, while US/Europe polypropylene utilization also declined. Resin sales in Brazil fell 2% quarter-over-quarter due to import competition, and chemicals sales softened, partially offset by tax credits and demurrage recoveries.

Debt Restructuring and Governance Overhaul in Focus

The market’s primary concern remains Braskem’s capital structure. Net debt/EBITDA stood at 6.74x at the end of Q2. Book value per share was -10.59, and the company’s current ratio was just 0.71, reflecting ongoing liquidity stress. Braskem Idesa, the Mexican subsidiary, defaulted on bond interest payments, leading to the reclassification of R$13.9 billion in borrowings as current liabilities.

In June 2026, Shine I Multi-Strategy Equity Investment Fund (IG4 Capital) acquired Novonor’s controlling stake, and a new shareholders’ agreement was signed with Petrobras. Braskem’s board and management were overhauled, with a mandate to prioritize debt restructuring, liquidity preservation, and operational efficiency. The company is in advanced talks with creditors covering more than $10 billion in debt. Chapter 15 bankruptcy recognition was filed in New York, and rating agencies S&P and Fitch downgraded the company to default-equivalent ratings.

Industry and Macro Conditions Remain Challenging

The global petrochemical industry faces persistent oversupply, with consultants estimating excess polyethylene capacity at 20 million tons, about 15% of global capacity. Demand has remained subdued, and trade tensions, new capacity additions, and currency volatility have added to uncertainty. The Q2 spike in spreads from Middle East supply disruptions is expected to fade as global supply chains normalize.

In Brazil, new antidumping duties on US and Canadian polyethylene imports and extended chemical industry tax credits provide some support but are insufficient to offset the impact of lower international margins. Currency swings have also affected results: the Brazilian real’s 22.1% devaluation in 2024 hurt net income, while a stronger real in Q2 2026 pressured margins further.

Legal and Environmental Liabilities Add to Uncertainty

Braskem continues to face significant liabilities from the Alagoas geological disaster, with lawsuits totaling nearly $1 billion and a Dutch court ruling in July 2024 holding the company liable. As of June 2026, 99.9% of residents had been relocated and R$4.2 billion paid out, but R$3.2 billion in provisions remain. A new R$4 billion lawsuit was filed by the state of Alagoas in July 2026, adding to the legal overhang.

Analyst sentiment has deteriorated, with Bank of America, JPMorgan, Bradesco, Citigroup, and Weiss Ratings all downgrading Braskem to “Sell” or “Underperform” since June, and price targets ranging from $1.50 to $3.40. The stock trades at a discount to peers, reflecting skepticism about recovery prospects and the risk that any restructuring could significantly dilute or eliminate existing equity holders. While some institutional investors have increased positions, overall flows remain negative.

Braskem’s path forward depends on the outcome of creditor negotiations, the durability of any operational improvements, and the company’s ability to navigate persistent industry headwinds and legal uncertainties. Near-term results remain highly sensitive to external market conditions and the evolving restructuring process.